Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting

Troels Brynskov, Caroline Schmidt Laugesen, Torben Lykke Sørensen

16 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{b9cee0d2e2354c5a9c0dc14d41f9584a,

title = "Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting",

author = "Troels Brynskov and Laugesen, {Caroline Schmidt} and S{\o}rensen, {Torben Lykke}",

year = "2013",

month = may,

doi = "10.1111/aos.12014",

language = "English",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Intravitreal ranibizumab for diabetic macular oedema

T2 - 1-year experiences in a clinical setting

AU - Brynskov, Troels

AU - Laugesen, Caroline Schmidt

AU - Sørensen, Torben Lykke

PY - 2013/5

Y1 - 2013/5

U2 - 10.1111/aos.12014

DO - 10.1111/aos.12014

M3 - Journal article

C2 - 23280048

SN - 1755-375X

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

ER -